pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Apr 29·1 min read
save

Report shows modest health equity gains but experts warn they may not last

Apr 29, 2026·read at STAT ↗Negative

A new Commonwealth Fund report covering 2022 to 2024 highlights several state-level actions that narrowed health disparities. Two states broadened Medicaid eligibility, many expanded postpartum coverage for new mothers, and enrollment in Affordable Care Act marketplace plans rose sharply.

These policy changes helped reduce gaps in access to care across the United States, according to the study’s authors.

Nevertheless, researchers caution that the improvements could be short‑lived. They point to potential setbacks from policies enacted during the second Trump administration, such as alterations to insurance coverage rules, vaccine policy changes, and reductions in diversity, equity and inclusion programs.

Political scientist Miranda Yaver warned that the persistent racial inequities may worsen if these policy shifts take hold, underscoring the fragility of recent gains.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “New report shows some health equity wins. Experts fear they will be short-lived”

read at STAT ↗
947 words · retrieved Apr 29
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
GILEAD
drugs
Undisclosed
topics
Vaccine5Breast Cancer2Oncology2Vaccines

related stories

  • 2d agoCaribou layoffs could wipe out 90% of staffBioSpace
  • May 29STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and moreSTAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: Matchpoint makes $150M; KymaThera corrals $80MFierce Biotech
  • Sep 8Inhibrx’s OX40 agonist add-on beats Keytruda alone in head and neck cancerBioSpace
  • Sep 1Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?Fierce Biotech